Ramipril, a commonly prescribed blood pressure medicine, is in short supply in the UK, and availability is expected to stay constrained until at least the end of October 2026. Both outlets report ongoing limitations on supplies rather than a return to normal availability.
The Daily Record and The Mirror describe the shortage in terms of the expected timeline, indicating that stock levels remain insufficient to fully meet demand in the near term. The Mirror frames its update as an “October supply limit,” while the Daily Record explains the shortage more generally and notes that the restricted supply period is expected to extend to late October.
Across both reports, the central point is the same: patients and prescribers are likely to face continued constraints around ramipril supply through the remainder of 2026, with the end of October identified as the earliest time when limitations may ease.
